David Mills

New research suggests that people with insomnia who use melatonin supplements for more than a year have a higher risk of heart failure than those who don’t use the popular sleep aid.

A new Gallup poll indicates that the obesity rate among U.S. adults has declined over the past three years as the number of people utilizing GLP-1 weight loss drugs like Ozempic and Wegovy has risen sharply.

A new Gallup poll indicates that the obesity rate among U.S. adults has declined over the past three years as the number of people utilizing GLP-1 weight loss drugs like Ozempic and Wegovy has risen sharply.

Affordable Care Act open enrollment runs from November 1 through January 15. Monthly premiums for ACA health insurance plans and out-of-pocket costs are expected to increase significantly in 2026.

California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say consumers will be able to purchase a five-pack of insulin pens for $55 in January 2026.

Rectal Bleeding in Young Adults Linked to 8.5 Times Higher Risk of Colorectal Cancer

The Medicare open enrollment period begins on October 15 for older adults who wish to enroll in or change their current health insurance plans. There may be fewer Medicare Advantage plans available, although the average premium is expected to decrease.

Higher doses of weight loss medications like Ozempic and Wegovy could help treat obesity. In two new studies, people taking 7.2 mg doses of semaglutide lost more weight than those who took smaller doses or received a placebo.

Health officials expect the upcoming 2025–26 flu season to be moderate compared to last year, but experts say everyone who is eligible should get vaccinated against influenza this fall.

Researchers say GLP-1 medications like Ozempic and Wegovy may not be as effective for those with emotional eating issues who overeat due to depression, boredom, or anxiety.